Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Chief R&D Officer
-
Stock Symbol
-
NKTR on Nasdaq
Jonathan Zalevsky - trading volume in the past year for Nektar Therapeutics
Holdings reported by Jonathan Zalevsky for Nektar Therapeutics
Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
Common Stock |
327K |
$307K |
$0.94 |
Dec 19, 2024 |
Direct |
|
|
Stock Option |
375K |
|
|
Dec 13, 2024 |
Direct |
Common Stock |
|
Transactions reported by Jonathan Zalevsky for Nektar Therapeutics
Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.